Saletan S - Search Results

1

Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study.

Castellano D, Bajetta E, Panneerselvam A, Saletan S, Kocha W, O'Dorisio T, Anthony LB, Hobday T; RADIANT-2 Study Group. Castellano D, et al. Among authors: saletan s. Oncologist. 2013;18(1):46-53. doi: 10.1634/theoncologist.2012-0263. Epub 2012 Dec 21. Oncologist. 2013. PMID: 23263288 Free PMC article.

2

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.

Fazio N, Granberg D, Grossman A, Saletan S, Klimovsky J, Panneerselvam A, Wolin EM. Fazio N, et al. Among authors: saletan s. Chest. 2013 Apr;143(4):955-962. doi: 10.1378/chest.12-1108. Chest. 2013. PMID: 23187897 Clinical Trial.

3

Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases.

Lebwohl D, Anak O, Sahmoud T, Klimovsky J, Elmroth I, Haas T, Posluszny J, Saletan S, Berg W. Lebwohl D, et al. Among authors: saletan s. Ann N Y Acad Sci. 2013 Jul;1291:14-32. doi: 10.1111/nyas.12122. Epub 2013 May 9. Ann N Y Acad Sci. 2013. PMID: 23659703 Review.

4

A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer.

Cope S, Zhang J, Saletan S, Smiechowski B, Jansen JP, Schmid P. Cope S, et al. Among authors: saletan s. BMC Med. 2014 Jun 5;12:93. doi: 10.1186/1741-7015-12-93. BMC Med. 2014. PMID: 24898705 Free PMC article.

5

Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe.

Jerusalem G, Neven P, Marinsek N, Zhang J, Degun R, Benelli G, Saletan S, Ricci JF, Andre F. Jerusalem G, et al. Among authors: saletan s. BMC Cancer. 2015 Oct 24;15:787. doi: 10.1186/s12885-015-1762-3. BMC Cancer. 2015. PMID: 26498283 Free PMC article.

6

Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer.

André F, Neven P, Marinsek N, Zhang J, Baladi JF, Degun R, Benelli G, Saletan S, Jerusalem G. André F, et al. Among authors: saletan s. Curr Med Res Opin. 2014 Jun;30(6):1007-16. doi: 10.1185/03007995.2014.887002. Epub 2014 Feb 3. Curr Med Res Opin. 2014. PMID: 24490834 Free article.

7

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

Arlin Z, Case DC Jr, Moore J, Wiernik P, Feldman E, Saletan S, Desai P, Sia L, Cartwright K. Arlin Z, et al. Among authors: saletan s. Leukemia. 1990 Mar;4(3):177-83. Leukemia. 1990. PMID: 2179638 Clinical Trial.

8

Mitoxantrone: an active, new antitumor agent with an improved therapeutic index.

Saletan S. Saletan S. Cancer Treat Rev. 1987 Dec;14(3-4):297-303. doi: 10.1016/0305-7372(87)90021-1. Cancer Treat Rev. 1987. PMID: 3326667 Review. No abstract available.

9

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.

Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, Reidy-Lagunes DL, Soares HP, Strosberg JR, Kohn EC, Kunz PL; NET CTPM participants. Singh S, et al. J Natl Cancer Inst. 2023 Sep 7;115(9):1001-1010. doi: 10.1093/jnci/djad096. J Natl Cancer Inst. 2023. PMID: 37255328 Free PMC article.

10

Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients.

Nightingale SD, Saletan SL, Swenson CE, Lawrence AJ, Watson DA, Pilkiewicz FG, Silverman EG, Cal SX. Nightingale SD, et al. Among authors: saletan sl. Antimicrob Agents Chemother. 1993 Sep;37(9):1869-72. doi: 10.1128/AAC.37.9.1869. Antimicrob Agents Chemother. 1993. PMID: 8239598 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters